Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer.
Martin P NilssonAnders JohnssonJonas SchermanPublished in: Radiation oncology (London, England) (2021)
Sarcopenia was associated with increased risks of both WBC G3+ toxicity and death following CRT for locally advanced anal cancer. In this study, radiation dose to PBM was not associated with WBC G3+ toxicity. However, PBM was not used as an organ at risk for radiotherapy planning purposes and doses to PBM were high, which may have obscured any dose-response relationships.